ACE-2223

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameACE-2223
Drug Alias NameACE-2223ACE-2223-1
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsTAR DNA binding protein 43 modulators
TargetsTAR DNA binding protein 43
Therapy Area/IndicationsNerve DegenerationAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcelot Inc
China Registration ClassN/A

Develop Information

Active CompaniesAcelot Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A